SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Sigmund Freud — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSigmund Freud
Date of birth1856-05-06
IdentifiersMRN HR-ET005-SYN-TD; SSN (made up) 000-05-8403
Document date1930-08-24
AuthorAnton Reinholt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Twelve-week review: five weeks without smoking and the new obturator. [S]

History of Present Illness

Mr. Freud returns twelve weeks after intake. He stopped smoking on his quit date five weeks ago. In the second week he smoked one cigar after a dinner with colleagues, felt worse for it, and has not smoked since; he did not treat it as a reason to give up. He uses the 21 mg patch each morning and three to five lozenges a day, and takes varenicline 1 mg twice daily. He sleeps well and his mood is steady. Dr. Vasquez-Lindqvist fitted the new obturator this morning, and with it there is no nasal leakage. He has had four speech-language therapy sessions since the last visit. His head and neck surgeon's yearly examination two weeks ago, with flexible endoscopy, found no recurrence and no second cancer. His pain is 3 of 10. [S]

ElementDetail
TobaccoNo smoking for five weeks except one cigar in the second week
TreatmentVarenicline 1 mg twice daily; 21 mg patch; three to five lozenges a day
New obturatorFitted this morning; no nasal leakage
SurveillanceSurgeon's yearly examination two weeks ago: no recurrence
Pain3 of 10

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight up; appetite better since stopping smoking
Ears, nose, mouth, and throatNegativeNo nasal leakage with the new obturator; no sore, lump or bleeding
RespiratoryNegativeMorning cough almost gone
PsychiatricNegativeMood steady; cravings brief and manageable

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four daysOne tablet daily for three days, then twice daily for four days, after foodOral route1930-06-01 to 1930-06-08completedS
Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeksOne tablet twice daily after foodOral route1930-06-08activeS
Nicotine 21 mg/24 hours transdermal patch, one patch each morning from the quit date, for six weeksOne patch each morningTopical route1930-07-20 to 1930-08-31completedS
Nicotine 4 mg oral lozenge, one lozenge as needed for cravings, up to 10 a day, dissolved on the side away from the obturator; gum avoided because it sticks to the prosthesisOne lozenge as needed, up to 10 a dayOral route1930-07-20activeS
Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy siteTwo tablets three times dailyOral route1930-06-01activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1930-08-24Body height172cmS
1930-08-24Body weight59.8kgS
1930-08-24Body mass index (BMI) [Ratio]20.2kg/m2S
1930-08-24Systolic blood pressure132mm[Hg]S
1930-08-24Diastolic blood pressure78mm[Hg]S
1930-08-24Heart rate70/minS
1930-08-24Respiratory rate14/minS
1930-08-24Body temperature36.7CelS
1930-08-24Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1930-08-24Albumin [Mass/volume] in Serum or Plasma3.7g/dL3.5-5 g/dLNormalS
1930-08-24Pain severity in the past week - 0-10 numeric rating [Reported]3{score}S

Physical Exam

Vital signs recorded on 1930-08-24; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 132/78, pulse 70; weight 59.8 kg
MouthNew obturator well seated; no pressure areas; mucosa healthy; no mass or white or red patch
SpeechNormal resonance with the obturator in
SkinMild redness at the last patch site only

Problems

ProblemClinical statusVerificationCodeProvenance
Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smokingactiveconfirmed F17.290S — Synthetic modern coding; person-first language; not a claim about his real diagnosis.
Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillanceactiveconfirmed Z85.818S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic.
Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorlyactiveconfirmed Z90.09S — Synthetic modern coding anchored to his documented obturator.
Hypernasal speech and nasal leakage of liquids from a poorly sealing obturatorresolvedconfirmed R49.21S — Synthetic finding; resolved when the new obturator was fitted.
Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubsactiveconfirmed G89.29S — Synthetic modern coding anchored to his documented constant mouth pain.
Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smokingactiveconfirmed E78.5S — Synthetic finding on the intake lipid panel.
Weight loss of 4 kg in six months from painful chewing and leakage, with a low albuminactiveconfirmed R63.4S — Synthetic finding; resolved as weight and albumin recovered.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyTobacco use (cigars a day), readiness and quit dateEvery visitCompleted todayNo smoking for five weeks except one cigar in the second week; exhaled carbon monoxide 4 ppm (narrative)
Medication safetyVarenicline adherence and side effects (nausea, sleep, dreams, mood)Every visit; at least 12 weeks, extended to 24 weeks or moreCompleted todayTaking it twice daily; no side effects now; extended to at least 24 weeks
Medication safetyCombination nicotine replacement (patch and lozenge)From the quit date for at least 8 to 12 weeksCompleted today21 mg patch for six weeks, then 14 mg for four weeks; lozenges three to five a day; mild redness at patch sites
Self-managementBehavioral support (quitline and clinic sessions)Weekly calls around the quit date, then every two to four weeksCompleted todayWeekly quitline calls around the quit date; now every two weeks
Self-managementRelapse preventionEvery visitCompleted todayThe slip was reviewed without blame; plan for dinners and travel
ExaminationHead and neck surveillance examination (mouth, defect and neck)Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visitCompleted todaySurgeon's yearly examination with flexible endoscopy two weeks ago: no recurrence or second primary; mouth healthy today
ImagingHead and neck imagingOnly for symptoms or signs more than five years after treatmentNot indicatedNo symptoms or signs
ExaminationObturator fit, seal and hygieneEvery visitCompleted todayNew definitive obturator fitted this morning by Dr. Vasquez-Lindqvist; good seal
ExaminationSpeech and swallowing (hypernasality, nasal leakage)Every visit; speech-language therapy as neededCompleted todayFour therapy sessions since the corrective action; normal resonance with the new obturator
ExaminationWeight and nutritionEvery visitCompleted today59.8 kg
LaboratoryAlbuminBaseline and at three months while weight is recoveringCompleted todayAlbumin 3.7 g/dL, from 3.4
SurveyPain score and functionEvery visitCompleted today3 of 10, measured before the new obturator was fitted
Medication safetyAcetaminophen daily dose (no more than 3,000 mg)Every visitCompleted today3,000 mg a day
Medication safetyOpioidsAvoid long-term opioidsNot indicatedNot needed

Goal progress:

Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022)

Follow-up: Patch step-down from next week. Quitline every two weeks. Two more speech-language therapy sessions. Five-month review in nine weeks with blood count, albumin, kidney function and ALT. Next scheduled visit 1930-09-28: subsequent annual wellness visit. [S]